Concepedia
Statistics
Publications
19
Citations
1.2K
H-Index
16
Active since
2006
Affiliations
Beijing Anzhen Hospital(Current)
Capital Medical University
Peking University
The University of Texas MD Anderson Cancer Center
Beijing Jishuitan Hospital
Yong Luo is an author at Beijing Anzhen Hospital specializing in oncology, molecular oncology, and medicine.
Publications per year
2006–2019
Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
Likun Li, Styliani Karanika, Guang Yang et al. · Science Signaling · 2017 · 304 citations
Medicine, Oncology, Pharmacology +17
Role of Wnt/β‐catenin signaling pathway in epithelial‐mesenchymal transition of human prostate cancer induced by hypoxia‐inducible factor‐1α
Yongguang Jiang, Yong Luo, Dalin He et al. · International Journal of Urology · 2007 · 218 citations
Life Sciences, Cancer Biology, Oncology +17
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer
Rong Xiang, Daiqing Liao, Tsu‐Yao Cheng et al. · British Journal of Cancer · 2011 · 174 citations · Full text
Medicine, Cell Biology, Oncology +17
Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells
Ling Lan, Yong Luo, Dai Cui et al. · International Journal of Oncology · 2013 · 77 citations · Full text
PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer
Bo Liu, Likun Li, Guang Yang et al. · Clinical Cancer Research · 2019 · 77 citations · Full text
1–5 of 19